<--- Back to Details
First PageDocument Content
Organofluorides / Celecoxib / Pfizer / Pyrazoles / Sulfonamides / European Medicines Agency / Familial adenomatous polyposis / Polyp / Medicine / Oncology / COX-2 inhibitors
Date: 2014-02-19 00:50:37
Organofluorides
Celecoxib
Pfizer
Pyrazoles
Sulfonamides
European Medicines Agency
Familial adenomatous polyposis
Polyp
Medicine
Oncology
COX-2 inhibitors

a?-ePR-zafl !9ttE + DEPT OF HERLTH

Add to Reading List

Source URL: www.hkam.org.hk

Download Document from Source Website

File Size: 558,58 KB

Share Document on Facebook

Similar Documents

The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMPFINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

DocID: 1vrLd - View Document

7 May 2018 EMAHuman Medicines Research and Development Support Division European Medicines Agency Guidance for applicants seeking access to PRIME scheme

DocID: 1vlIp - View Document

The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 23 January 2003 CPMP/SWP

DocID: 1ucvu - View Document

2 March 2016 EMAExternal guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use

DocID: 1sVev - View Document

European Medicines Agency: Celebrating 20 years

DocID: 1sUY9 - View Document